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A B S T R A C T
Diaphyseal fractures represent a complex biological entity that could often end into impaired bone-healing, with
delayed union and non-union occurring up to 10% of cases. The role of the modern orthopaedic surgeon is to
optimize the fracture healing environment, recognize and eliminate possible interfering factors, and choose the
best suited surgical ﬁxation technique. The impaired reparative process after surgical intervention can be
modulated with diﬀerent surgical techniques, such as dynamization or exchange nailing after failed in-
tramedullary nailing. Moreover, the mechanical stability of a nail can be improved through augmentation
plating, bone grafting or external ﬁxation techniques with satisfactory results. According to the “diamond
concept”, local therapies, such as osteoconductive scaﬀolds, bone growth factors, and osteogenic cells can be
successfully applied in “polytherapy” for the enhancement of delayed union and non-union of long bones dia-
physeal fractures. Moreover, systemic anti-osteoporosis anabolic drugs, such as teriparatide, have been proposed
as oﬀ-label treatment for bone healing enhancement both in fresh complex shaft fractures and impaired unions,
especially for fragility fractures. The article aims to review the biological and mechanical principles of failed
reparative osteogenesis of diaphyseal fractures after surgical treatment. Moreover, the evidence about the
modern non-surgical and pharmacological options for bone healing enhancement will discussed.
1. Introduction
Long bones diaphyseal fractures have typical morphology patterns,
with displacement and comminution which are held responsible for low
bone contact and vascular supply disruption that adversely aﬀects the
healing process. Other factors, such as severe bone defects, soft tissue
damages, open fractures and patients' related risk factors could lead to
delayed unions and non-unions, which are estimated to occur in 1.9%
and 10% of all diaphyseal fractures (Mills et al., 2017; Nandra et al.,
2016).
Modern research eﬀorts in orthopaedics are oriented into bone
callus enhancement by surgical, pharmacological, cellular, and bio-
physical strategies in order to improve fracture healing process (Djouad
et al., 2009; Mark Fisher et al., 2013; Hannemann et al., 2014).
The current article aims to review the bio-mechanical basis of failed
reparative osteogenesis in diaphyseal fractures. Moreover, the surgical,
biological, physical and pharmacological treatment options for bone
healing enhancement of acute fractures and delayed unions will be
highlighted.
2. Biology and bio-mechanical basis of surgical treatment in
diaphyseal fractures
Diaphyseal fractures of long bones can heal by either direct fracture
healing or indirect fracture healing. The healing pathway of a diaphyseal
fracture depends on the complexity of fracture pattern (simple or multi-
fragmentary fracture), the blood supply and the bio-mechanical en-
vironment at the fracture site consequent to the operative or non-op-
erative treatment (Table 1).
Historically Wolﬀ's law (Wolﬀ, 1986), in 1982 ﬁrst described the
physiological response of normal bone to its mechanical environment
during bone healing and remodelling. Then, Frost's concept of the
“mechanostat” deﬁned bone homeostasis as an independent unit re-
sponding to variations in the mechanical environment (Frost, 1987).
One of the most accepted theories is Perren's “strain theory” (Perren,
1989), in which is stated that bony bridging between the distal and
proximal callus can only occur when local strain (i.e., deformation) is
less than the forming woven bone can tolerate (Perren, 1989). There-
fore, when the interfragmentary strain (IFS), expressed as the function
of movement and gap fracture width, is< 2% bone repair occurs by
direct healing, while for intermediate amount of IFS (5–10%) the
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fracture heals by indirect healing. If the stresses exceed the deformation
tolerance of the fracture gap, producing a high-strain environment
(IFS > 10%), the fracture will eventually culminate in pseudarthrosis
(Perren, 2003). The same deforming force produces more strain at the
site of a simple fracture than at that of a multi-fragmentary fractures,
which tolerate more motion between the two main fragments because
the overall movement is shared by several fracture planes.
Claes et al. demonstrated that in diaphyseal simple fractures, direct
healing can only occur when the cortical continuity of the fractured
fragments is restored and rigid ﬁxation is provided, resulting in low
inter-fragmentary movements (Claes and Heigele, 1999; Shapiro, 1988;
Claes et al., 1997). Particularly, a gap between fragments lower than
0.01mm an inter-fragmentary strain lower than 2%, is needed in order
to have the fracture unite by intramembranous ossiﬁcation (Shapiro,
1988). Therefore, surgical techniques with absolute stability, such as
plate internal ﬁxation, are mandatory. In complex, multi-fragmentary,
diaphyseal fractures the process of indirect healing is enhanced by
micro-movements and weight-bearing, therefore anatomic reduction
and absolute stability are not required. Relative stability osteosynthesis
techniques, such as external ﬁxation, intramedullary nailing (IMN) and
bridging plating, are more suitable since they further tolerate de-
forming forces. If the interfragmentary deformation is excessive or the
fracture gap is too wide, bony bridging by hard callus is not obtained in
spite of good callus formation, and could result in malunion, delayed
union or hypertrophic non-union. On the other hand, if the ﬁxation
device is too stiﬀ and the gap too wide will be produced a low-strain
environment which will result in delayed healing and non-union (Claes
et al., 1997). Therefore, the choice of the type of treatment aﬀect the
stability and lead to a speciﬁc pathway of bone repair. The ideal ﬁxa-
tion system should provide a temporary support that protect callus
formation and lead the fracture to union in the shorter time possible,
allowing anatomy restoration and early mobilization.
More recent evolution of these theories, highlighted the role of the
“biological ﬁxation” (Perren, 2003). ‘Biological’ internal ﬁxation avoids
anatomic reduction, especially of the intermediate fragments, and
prefers indirect reduction. Indirect reduction aims only to align the
fragments and limits exposure of the bone thus reducing the surgical
trauma (Baumgaertel et al., 2002). This principle applies equally to
locked intramedullary nailing (IMN), bridge plating such as minimally
invasive percutaneous osteosynthesis (MIPO) and less invasive stabili-
zation system (LISS) systems, and internal ﬁxator-like devices (Bong
et al., 2007; Saini et al., 2013; Zhang et al., 2017). Callus formation is,
therefore, achieved through ﬂexible ﬁxation using wide bridging of the
fractured gap, and avoiding an extensive implant-to-bone contact. This
should provide the optimal biological conditions for healing rather than
absolute stability. Results of this approach showed excellent results
becoming the preferred ﬁxation especially for unstable, complex,
multifragmentary diaphyseal fractures (Piétu and Ehlinger, 2017;
Celebi et al., 2006; Kesemenli et al., 2002; El-Desouky et al., 2016). On
the other hand, for simple shaft fractures, rigid ﬁxation with absolute
stability still represent the ideal treatment (Wenger et al., 2017; van de
Wall et al., 2019). Although correct surgical indications generally lead
to good clinical outcomes, delayed union and non-unions rates are still
a consistent threat (Table 2).
In 2016, Elliot et al. presented their bone healing and nonunion theory
(BHN) with the aim to produce an uniﬁed theory that links established
facts about the physiology of bone and homeostasis with those involved
in the healing of fractures and the development of nonunion. The key
point is that, according to Wolﬀ's and Frost's theories, a prolonged in-
crease in strain will result in increased bone formation, while prolonged
reduction in strain results in bone loss.
The homeostasis state is represented by a balance in osteoblast and
osteoclast function and consequent with a slow bone turnover. In case
of fracture, the so-called bone-healing unit act as a speciﬁc functional
entity which produces a physiological response to the biological and
mechanical environment leading to the normal healing of bone. The
bone-healing unit evolves trough the diﬀerent stages of reparative os-
teogenesis producing diﬀerent tissues (hematoma, granulation tissue,
cartilage and bone), that can tolerate various levels of strain.
The theory recognize three diﬀerent types of bone healing me-
chanisms. A normal response to fracture in which initially, the strain is
high, granulation tissue forms and the healing process gradually stiﬀens
the area until the strain reduces and bone can form and ﬁnally remodel
through normal homeostasis. This type correspond to the type of bone
healing seen after nonoperative treatment of fractures and operative
ﬁxation with relative stability. The healing by callus type occurs when
higher strains are within tolerable levels maximizing the formation of
bone with large volumes of callus. It is typically associated with relative
stability surgical techniques such as intramedullary nailing. Then pri-
mary bone healing type occurs when a fracture is treated with anatomic
reduction and absolute stability. In this low-strain environment, bone
healing is the result of normal homeostatic remodelling of the local
bone, therefore, healing is slow and there is no callus formation.
Table 1
Diﬀerent bone healing processes promoted according to osteosynthesis system in long bone shaft fractures (Claes and Heigele, 1999; Perren, 2003).
Osteosynthesis type Fracture type Interfragmentary strain Healing pathway Callus type
Intramedullary nail Simple
Multifragmentary
+
++
Direct
Indirect
Cortical
Periosteal
Endosteal
Dynamic compression plate Simple − Direct Cortical
Locking compression plate Multifragmentary ++ Indirect Periosteal
Endosteal
External ﬁxator Open
Simple
Multifragmentary
+
+++
Direct
Indirect
Cortical
Periosteal
Endosteal
Table 2
Non-union rates of non-unions after surgical and conservative treatment of
diaphyseal fractures (Nandra et al., 2016; Rupp et al., 2018; Zura et al., 2016).
Fracture Note Treatment Non-union
rate
Humeral
shaft
Debate over conservative vs
operative management with
plate ﬁxation
Conservative
Plate ﬁxation
Anterograde IMN
Retrograde IMN
0–13%
0–4%
1.6–33%.
4.5%
Femoral
shaft
Requires stable ﬁxation, early
mobilization. MIPO and LISS
are best plating choices. IMN
ﬁxation is the preferred system
(dynamization option)
Plate ﬁxation
Antegrade IMN
Unreamed
Retrograde IMN
2–7%
2.5%
13.8%
5.8%
Tibial
shaft
High energy trauma, associated
soft tissue injury. In plating risk
for wound complications.
IMN ﬁxation is the preferred
system (dynamization option)
Conservative+ cast
Plate ﬁxation
Antegrade IMN
Unreamed
1–17%
1–7%
0–5.5%
11%
G. Marongiu, et al. Bone Reports 12 (2020) 100249
2
According to the BHN theory nonunion occurs primarily due to me-
chanical or biological origin, representing the two main path that can
lead to bone healing impairment. Mechanical instability recovers the
dominant role in clinical practice, and in most nonunions there is an
intact bone-healing unit maintaining its biological potential of healing.
When very high strain persists, the movement at the fracture site breaks
down the bone-healing unit. Therefore, the main strategy for bone
healing enhancement is represented by the restoration of mechanical
stability and reduction of strain. In addition biological factor can po-
sitively or negatively modulate the response of the bone-healing unit to
strains and the mechanical environment.
3. Biological factors inﬂuencing bone healing
The process of fracture healing can suﬀer from many biological
factors that may interfere with its development. Biological factors are
classiﬁed in patient – related factors (i.e. living habits and comorbidity)
and fracture – related factors (i.e. topography, soft tissue injuries) (Zura
et al., 2016; Santolini et al., 2015) (Table 3).
Age is the patient – related factors that plays the most important role.
The periosteum of children and young adults is rich in osteoblasts and
has a strong blood ﬂow. In the elderly, instead, the periosteum is par-
tially ﬁbrous and originates, therefore, a slower callus formation
(Cheung et al., 2016). In osteoporotic patients, both type I (post-
menopausal estrogenic deﬁciency) and type II (aging), a delayed ex-
pression of estrogenic receptor was shown during the healing process
that correlated to impairment in callus formation capacity. Other fac-
tors including progenitor cell recruitment, diﬀerentiation, and pro-
liferation during the early phase of fracture healing are reduced due to
low production of growth factors (BMP) and both qualitative and
quantitative deﬁciency of mesenchymal cells (Cheung et al., 2016).
Nikolaou et al. reported that the average time of consolidation of dia-
physeal femoral fractures treated with intramedullary nailing in pa-
tients with osteoporosis was 3 weeks longer compared to a control
group of healthy patients (Nikolaou et al., 2009). Moreover, surgical
procedures of fractures ﬁxation in osteoporotic patients have generally
poorer outcome and higher rates of complications such as loss of re-
duction, implant failure and delayed union or non-union, instead
(Marongiu et al., 2013). Osteoprogenitor cells activity is inﬂuenced by
genetic factors. Recently Ma and O'Connor, in an experimental study on
rats, identiﬁed several genes (C57BL/6, DBA/2, C3H9) that aﬀected the
process of fracture consolidation (Manigrasso and O'Connor, 2008). In
mice with C57BL/6 genes, fracture consolidation was achieved in a
shorter time. Hofmann et al. have shown altered cell viability and down
regulated gene expression of signalling molecules (Wnt-, IGF-, TGF-β-,
and FGF) in osteoblasts of patients suﬀering from hypertrophic non-
union of long bones (Hofmann et al., 2008). Other speciﬁc molecules
polymorphisms and genetic proﬁles were reported to aﬀect both the
cellular diﬀerentiation and the process of enchondral callus generation
(Jepsen et al., 2008).
Diabetes can signiﬁcantly compromise the healing process of a
fracture. Shaft fractures in patients with uncontrolled diabetes often
suﬀer impaired vascularization and therefore fracture healing is pro-
longed with a signiﬁcantly higher risk of complications such as im-
paired wound healing, delayed union, and non-union (Jiao et al.,
2015). On the other hand, patients under proper insulin therapy have
lower risk of delayed and non-union (Simpson et al., 2011).
Also some living habits of the patients represent a well-known risk
factors. Smoking increases the risk of delayed union and non-union;
nicotine inhibits cellular proliferation during repair processes by al-
tering the activity of macrophages, ﬁbroblast and osteoblasts. In addi-
tion, it acts as a vasoconstrictor, causing impaired perfusion resulting in
hypoxia and ischemia. Patients who smoke>10 cigarettes a day have
shown a deﬁcit of formation of hematoma at fracture site. The reduced
vascular supply lead to atrophic non-union (Adams et al., 2001; Ziran
et al., 2005).
In chronic alcoholics, high doses of Ethanol (> 1000 cc/day) in-
hibits the ossiﬁcation of newly-formed bone which is poorly miner-
alized and has reduced mechanical stability (Chakkalakal et al., 2005).
Also the use of NSAIDs for a period > 4weeks immediately after sur-
gery reduces osteoblastic activity and inhibition prostaglandin synth-
esis with delay in callus formation (Dodwell et al., 2010).
The patient's nutritional status, especially protein/amino acid mal-
nutrition, can negatively aﬀect fracture healing pathways, considering
that all the stages of bone healing are strictly regulated by protidic
mediators such as collagens and BMPs (Meesters et al., 2018). A sys-
tematic review examining the role that vitamin D plays in fracture
healing found variable results investigating the eﬀect of vitamin D on
the speciﬁc stages of bone healing. Vitamin D supplementation has been
shown to stimulate osteogenesis, increase the production of osteocalcin
and stimulate osteoclast-mediated bone resorption (Gorter et al., 2014).
Moreover, Vitamin D deﬁciencies seem to promote non-union devel-
opment (OR 1.14; 1.05–1.22) (Zura et al., 2016), therefore advice on
diet is important particularly for older fragile patients. Also adequate
calcium intake is required for callus mineralization; for patients older
than 50 years of age, the recommended daily intake of calcium is
1200mg and 800 UI of vitamin D (Fischer et al., 2018).
Fracture-related factors characterize the so-called “fracture person-
ality”. They include the injury mechanism (i.e. a high or low energy
trauma) and the vascular and soft tissue damage. Moreover, the number
and the comminution of fragments, the extension of inter-fragmentary
gap, the displacement and the type of surgery inﬂuence the healing
pattern (Lepri et al., 2018a).
In the last decades, several clinical trials and cohort studies at-
tempted to quantify the inﬂuence of all these factors on the healing
potential of diaphyseal fractures. In a recent multicentre observational
study, the FRACTING study, these general and local factors were
combined in a score, calculated immediately after the treatment, and
used in the attempt to predict the healing time of tibial diaphyseal
fractures (Massari et al., 2013). The authors concluded that patients
with higher scores more likely underwent non-union and had longer
healing time (Massari et al., 2018). The resulting score could be used
for selecting patients who might be receiving therapeutic interventions
to enhance fracture healing (i.e. surgical techniques, cell therapy,
growth factors, drugs, or physical stimuli).
4. Surgical strategies for bone healing enhancement
As mentioned before, the normal process of bone regeneration could
result impaired or simply insuﬃcient due to both mechanical and
biological underlying factors. Giannoudis et al. in their “Diamond
concept” theory, emphasized the role of mechanical environment as a
crucial factor for bone healing enhancement, in addition to other cell
and tissue-based engineering strategies (Giannoudis et al., 2007).
Table 3
Risk factors contributing to fracture delayed union and non-union (Zura et al.,
2016; Santolini et al., 2015).
Patient-related factors Fracture-related factors
Age High-energy trauma
Smoking Soft tissue injury
Alcohol consumption Open fracture with High Gustilo-Anderson
Grade
Poorly controlled diabetes Large inter-fragmentary gaps
Malnutrition, protein deﬁciency Complex or comminuted fractures
Reduced muscle mass,
sarcopenia
Biomechanical instability
Osteoporosis Large fracture haematoma
Vitamin D, calcium Infection
Post-menopausal females Prolonged immobilisation
Genetic polymorphisms Perioperative or prolonged non-steroidal
anti-inﬂammatory drugs (NSAID) use
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Surgical approaches aim to restore mechanical stability of the fracture
site and to stimulate or augment bone gap, through fracture ﬁxation
and bone grafting techniques, either alone or in combination. Each of
the proposed treatment have a diﬀerent eﬀectiveness according to the
type of bone healing impairment (delayed union, hypertrophic non-
union, hypotrophic and atrophic non-union) in which is applied
(Figs. 1, 2 and 3).
The graph shows that delayed union of tibial shaft fractures,
without bone defects, are more likely treated with nail dynamization
and early exchange nailing which provide additional biologic stimula-
tion at fracture site. Exchange nailing for femoral delayed union
showed lower success rates and is considered a second line therapy. No
evidence of surgical treatment for humeral delayed union is reported.
Reamed exchange nailing improves mechanical stability and pro-
vide biological stimulation trough auto-grafting. Augmentation plating
represents an eﬀective treatment for both femoral and humeral hy-
pertrophic nonunions which need primarily the enhancement of the
mechanical stability. Bone grafting augmentation improves the biologic
stimulation after plating.
Hypotrophic and atrophic non-unions are the result of a poor
biologic response at the fracture site. For humeral, tibial and femoral
hypotrophic and atrophic non-unions surgical interventions has to be
combined with bone grafting and/or other biologic treatments. For
femoral shaft fractures exchange nailing is regarded as second line
therapy, compared to augmentation plating. Humeral shaft fracture
beneﬁt both from compression and augmentation plating with bone
grafting (or biologics).
4.1. Nail dynamization
Nail dynamization provides fracture compression trough the re-
moval of interlocking screws of the IM nail, either proximal or distal to
the fracture site. The bio-mechanical pathway promoted by dynami-
zation is the enhancement of micro-movement at the fracture site re-
sulting in stimulation of osteogenesis (Glatt et al., 2017). However,
excess of movement could lead to loss of reduction and leg-length or
rotation discrepancies, particularly in highly comminuted fractures and
wide fracture gaps. Therefore, a fracture is considered suitable for dy-
namization only when suﬃcient stability at the fracture site is obtained.
Other risk factors for unsuccessful dynamization are open fractures and
unstable atrophic non-unions, whereas in unstable hypertrophic non-
unions dynamization is considered an appropriate treatment option
(Papakostidis et al., 2011).
In the past nail dynamization was recommended as the standard
procedure after locked intramedullary nailing of long bone shaft frac-
tures, 2 to 4months after the surgery, while nowadays it is indicated
mainly for delayed union or non-union (Egger et al., 1993). There is not
consensus about the best timing for the procedure but available results
suggest that dynamization of delayed union is more promising than
dynamization of femoral and tibial diaphyseal non-unions (Vaughn
et al., 2016). Vicenti et al. in their retrospective analysis of femoral
shaft fractures, suggested to perform dynamization between three and
six months after trauma. The overall healing rate was 94.1% for both
femoral delayed union and non-union (Vicenti et al., 2019). Litrenta
et al. in a large series of IMN dynamization for tibial shaft fracture,
reported a mean 5.2months from the trauma to the procedure. They
found out union in 83% of cases and reported worst results in patients
with a wide fracture gap (Litrenta et al., 2015).This technique cannot
be easily applied after IM nailing of a humeral shaft fracture while
humerus is not a weight bearing bone (Congia et al., 2019).
Fig. 1. Biomechanical rationale and eﬃcacy of surgical interventions for de-
layed unions of long bones shaft fractures (Litrenta et al., 2015; Vicenti et al.,
2019; Ateschrang et al., 2013).
Fig. 2. Biomechanical rationale and eﬃcacy of surgical interventions for hy-
pertrophic nonunions of long bones shaft fractures (Gogus et al., 2007; Brinker
and O'Connor, 2007; Kashayi-Chowdojirao et al., 2017).
Fig. 3. Biomechanical rationale and eﬃcacy of surgical interventions for hy-
potrophic and atrophic non-union of long bones shaft fractures (Gogus et al.,
2007; Dimitriou et al., 2005; Gessmann et al., 2016; Chiang et al., 2016).
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4.2. Exchange nailing
Exchange nailing involves removal of the IM nail, reaming, and
replacement with a larger nail at least one millimetre thicker in its
diameter. The main advantage of this technique is the additional me-
chanical stability provided from a larger diameter nail (Court-Brown
et al., 2018). Mechanical stiﬀness is often improved using a multiple
locking screws construct. Moreover, reaming procedure with sub-
sequent transport of mesenchymal stem cells into the non-union site,
act like an “internal autologous bone grafting” enhancing the healing
process (Ghiasi et al., 2017). Several studies reported successful results
after exchange nailing, with healing rate ranging from 72% to 96%
(Brinker and O'Connor, 2007). Recently, results of a large series of tibial
delayed union, reported superior success rate after exchange nailing
compared to nail dynamization (90% vs 83%; p=0.02) (Litrenta et al.,
2015). Some studies have reported lower non-union healing rates after
exchange nailing in femoral non-unions (Weresh et al., 2000) and
therefore was then recommended as a second line therapy.
4.3. Augmentation plating
Augmentation plating over a retained intramedullary nail is re-
ported as a viable option for managing long bones fracture non-unions.
Plating over a retained nail improve the stiﬀness of the construct, re-
ducing micromotions. Moreover, compression at non-union site can be
achieved through a LC – DCP. Results in the literature are substantially
satisfactory, even if not large series have been reported. Chiang et al.
obtained a 96.6% of healing in 30 femur fractures with augmentation
plating of after failed IMN as the index procedure (Chiang et al., 2016).
Excellent union rates were reported for the treatment of both tibial
(94.6%) (Ateschrang et al., 2013) and humeral shaft (97%) failed IMN
nailing (Gessmann et al., 2016).
4.4. External ﬁxation techniques
Several external ﬁxation techniques, with both mono-axial and ring
ﬁxators, have been proposed for delayed unions and non-unions of long
bones diaphyseal fractures. Ilizarov (circular) ﬁxators allow compres-
sion at the fracture site (axial dynamization and active compression),
which restores the cortical contact, confers stability to the fracture and
neutralizes inter-fragmentary strain, promoting bone healing trough
enchondral remodelling (Ilizarov, 1989). Aro has described this process
as “healing for second contact” (Aro et al., 2006). In case of recalcitrant
non-union, the ﬁbrous fracture site can be resected leaving a bone gap
which can be ﬁlled trough cortical compression.
The daily gradual (1 mm/day) distraction with ﬁxators, enhance
bone transport trough “distraction osteogenesis”, which involves in-
tramembranous ossiﬁcation pathways (direct healing) (Ilizarov, 2006).
High union rates up to 97% were reported in patients suﬀering from
femoral or tibial non-unions treated with a monolateral or circular
external ﬁxator. External ﬁxation showed its superiority compared to
the other techniques especially in the treatment of humeral non-unions
(98% union rate) and in the treatment of infected non-unions (Yin et al.,
2015).
5. Biological local approaches to enhance bone healing
In addition to the stability of mechanical environment, bone healing
can be modulated through the use of cell- and tissue-based engineering
therapies with osteoconductive, osteoinductive and osteogenic func-
tion.
Currently, we can classify the biotechnological systems for the en-
hancement of primary healing or management of delayed union and
non-unions of long-bone fractures in 3 main categories: osteoconduc-
tive scaﬀolds, growth factors and osteogenic cells (Table 4).
5.1. Bone grafting
Bone grafting techniques are applied in several orthopaedic and
trauma procedures to provide bone augmentation and regeneration is
needed. Cortical structural grafts, used as biological plates or in-
tramedullary support in combination with other internal ﬁxation de-
vices, improve mechanical stability (Gogus et al., 2007; Kashayi-
Chowdojirao et al., 2017; Marongiu, 2016).
Autologous bone graft (ABG) combines all properties required in a
biological graft: osteogenic, osteoconductive and osteoinductive prop-
erties. Limitations of ABG extensive use are the limited availability,
graft dimension and donor site morbidity (i.e. iliac crest or ﬁbula) (Sen
and Miclau, 2007).
Allogenic bone grafts (Allograft) are available in diﬀerent shapes and
dimension as cortical, cancellous, osteochondral and whole-bone seg-
ments. The main disadvantage of allograft is the loss of osteogenic
potential due to the removal of bone cells during the graft preparation.
ABG, both vascularized and non-vascularized, have been widely applied
in diaphyseal long bones fractures, with severe comminution and bone
loss, in support to osteo-synthesis techniques. Zhen reported excellent
results after plating and vascularized ABG for tibial shaft complex
fractures. All the patients achieved union, but 10 out 38 experimented
donor-site morbidities (Zhen et al., 2011). In a 45 patients' series,
structural allograft associated to ORIF for complex humeral and femoral
shaft fractures provided 93% and 88% union rates, respectively (Gogus
et al., 2007). Moreover, bone grafting represents an additional option in
all the osteoporosis related and so-called fragility fractures (Marongiu
et al., 2013). Several studies have shown that cortical strut allografts
represent a reliably solution in the treatment of periprosthetic femoral
fractures (Capone, 2017; Tomás Hernández and Holck, 2015; Marongiu
et al., 2019). Particularly, grafts have been applied successfully in type
B2 or B3 in young patients, in type C and in re-osteosynthesis of a
previously failed ﬁxation, with union rates ranging from 89 to 99%
(Tomás Hernández and Holck, 2015). Due to increased infection and
time to union, allograft struts should be used cautiously for the treat-
ment of Vancouver B1 factures (Moore et al., 2014). The application
cortical and cancellous ABG and allograft have been widely studied in
non-unions of long bones shaft fractures with consistent union rates
ranging from 80 to 94% (Kashayi-Chowdojirao et al., 2017; Miska et al.,
2016).
5.2. Bone substitutes
The demineralized bone matrix (DBM) is a highly processed allograft
without nearly 60% of the mineral content while collagens, non-col-
lagenous proteins and growth factors are maintained (Urist et al.,
1968). DBM allograft materials satisﬁes both principles of osteo-
conductive and osteoinductive healing. The osteoconductivity of the
DBM is conferred by providing a suitable matrix for cells to inﬁltrate,
populate and for generate new bone. DBM can also aid the healing
response through osteoinductive pathways, in which mesenchymal cells
are stimulated by native bioactive molecules to diﬀerentiate into bone-
forming cells, and can trigger the endochondral ossiﬁcation cascade at
the site of implantation (Boyce et al., 1999). DMB, due to its inferior
structural mechanical integrity than ABG and strut-allograft is mainly
applied for ﬁlling bone defects. Particularly, results in long bones
fracture surgery have shown good results. Lindsey et al. reported 90%
bone healing after DBM augmentation compared to 75% after iliac crest
autograft in 20 consecutive long bone fractures (Lindsey et al., 2006).
Another report showed shorter healing time when atypical sub-tro-
chanteric femoral fractures were treated with DBM in addition to IMN
ﬁxation (Kulachote et al., 2016). However, the clinical level of evidence
that supports the use of DBM in trauma and orthopaedic surgery is
limited and consists mainly of poor quality and retrospective case-series
and the resulting Grades of Recommendation are very low (van der Stok
et al., 2017).
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Calcium sulphate, calcium phosphate (CaP) ceramics and cements,
bioactive glass or their combinations are the currently more used syn-
thetic bone substitutes. They all share similar mechanical character-
istics and the aim to mimic the osteoconductive properties of bone graft
and are mainly used as void ﬁllers in large segmental defects (Calcei
and Rodeo, 2019). The use of β-tricalcium phosphate combined with
demineralized bone matrix as a primary hybrid grafting were studied in
femoral and tibial comminuted fractures treated by plate ﬁxation. An-
tibiotics powder was added to the graft in all open fractures. All the
fractures healed with solid union without any implant failure (Ayoub
and El-Rosasy, 2014). The application of bioactive glass showed pro-
mising results (Civinini et al., 2017). Sun et al., in a RCT, compared the
use of reamed IMN alone versus reamed IMN combined with Bioglass
45S5 grafting at the fracture sites for treating 78 high-energy tibial
shaft fractures. All the patient in the experimental group healed within
6months while 4/38 patients (10.5%) in the control group underwent
to delayed union (Sun et al., 2009). Moreover, these substitutes may be
combined with biologically active osteoinductive and osteogenic sub-
strates such as bone marrow aspirate, platelet rich plasma, or BMPs
(Calcei and Rodeo, 2019).
5.3. Growth factors
Synthetic growth factors, including Bone morphogenetic proteins
(BMP), ﬁbroblast growth factors (FGF), vascular endothelial growth
factor (VEGF), platelet-derived growth factor (PDGF), and insulin-like
growth factor (IGF), have been proposed with regard to their stimula-
tion activity of bone healing.
The family of Bone Morphogenetic Proteins (BMP), mainly BMP-2,
BMP-4 and BMP-7, has found wide application in the orthopaedic ﬁeld
(Dimitriou et al., 2005; Calori et al., 2015; Cho et al., 2002). BMPs
regulate the activity of osteoprogenitor cells and their diﬀerentiation
into osteoblasts and stimulate chondrocyte proliferation during en-
dochondral bone formation. In experimental models of fracture healing,
BMP-2 and BMP-7 increased the amount of cartilage and bone forma-
tion within the callus and reduced the time needed to reach callus
mineralization and bone remodelling (Yu et al., 2010). Several clinical
trials showed that BMP-2 and BMP-7 reduced the risk of fracture non-
union and decreased the time to union following surgical treatment of
tibial shaft fractures (Ristiniemi et al., 2007). Govender et al. in a RCT
of 450 open tibia shaft fractures, showed that the application of
1.50mg/mL recombinant (rh) BMP-2 was useful in order to reduce the
healing time and the risk of non-union (Govender et al., 2002). Other
studies have shown controversial results. Aro et al. showed that the
healing of open tibial fractures treated with reamed intramedullary nail
ﬁxation was not signiﬁcantly accelerated by the addition of an ab-
sorbable collagen sponge containing rhBMP-2 (Aro et al., 2011). Lyon
et al., in patients with closed tibial fractures treated with reamed in-
tramedullary nailing, found that the time to fracture union and pain-
free full weight-bearing were not signiﬁcantly reduced by 2.0-mg/mL of
rhBMP-2/CPM compared with standard of care alone (Lyon et al.,
2013).
The application of BMPs to treat fracture non-unions, according to
several authors appeared to be a favourable alternative to autologous
bone grafting. Particularly, BMP-2 or BMP-7 resulted in similar union
rates (75–89%) as those achieved with autologous bone grafting (Calori
et al., 2008; Kanakaris et al., 2008). As reported by Klenke and Sie-
benrock, interestingly, RCTs investigating the application of BMPs and
autograft have not been published so far (Klenke and Siebenrock,
2016). Although the initial enthusiasm, several concerns have been
raised about the use of BMPs. The induction of heterotopic ossiﬁcations
has been reported from 9 to 18% of tibia fractures treated with BMPs,
even if conversely other studies did not show a direct correlation (Aro
et al., 2011; Lyon et al., 2013). Moreover, other morbidities are asso-
ciated with its use, particularly in oﬀ-label and high dosage use, in-
cluding the potential for carcinogenesis, renal and hepatic failure, and
compartment syndrome (Barcak and Beebe, 2017; Guo et al., 1999). In
conclusion, the actual evidence seems to limit the use of rhBMP-2 for
treating open tibia fractures, speciﬁcally, Gustilo-Anderson type 3 in-
juries, and the use of rhBMP-7 for treating tibia shaft non-unions
(Barcak and Beebe, 2017).
Fibroblast growth factors are secreted by monocytes, mesenchymal
stem cells, osteoblasts and chondrocytes, from the early stages of
fracture healing throughout the whole healing process. Kawaguchi et al.
reported the results of rhFGF for treating tibial shaft fracture in a
clinical trial including 70 patients (Kawaguchi et al., 2010). Reamed
intramedullary nailing represented the standard care, then patients
were randomly injected with either placebo or 0.8 mg rhFGF-2 or
2.4 mg rhFGF-2 at the fracture site. The authors found at x-rays analysis
shorter healing time and higher facture union rates in both rhFGF
treated groups compared to the hydrogel-only treated group.
Platelet-derived growth factor is a signalling molecule that is re-
leased by degranulating platelets in the early phases of fracture healing
through its important role in chemotaxis. Although, the application of
rhPDGF in bone healing have been approved by the FDA for hindfoot
ankle fusion (DiGiovanni et al., 2013), currently there are no PDGF
agents approved speciﬁcally for use in fracture healing (Calcei and
Rodeo, 2019). Similarly, vascular endothelial growth factor has also
been demonstrated to have osteoinductive function (Keramaris et al.,
2008). However, all the available studies have been performed in dif-
ferent animal models (Kentleach et al., 2006; Eckardt et al., 2003;
Buettmann et al., 2019), there is not available for clinical use.
5.4. Cells therapies
Autologous bone marrow aspirate concentrate (BMAC) has demon-
strated positive outcomes in the treatment of musculoskeletal injuries.
Bone marrow, speciﬁcally red marrow, contains 2 types of adult stem
cells: hematopoietic stem cells and mesenchymal stem cells (MSCs). The
MSCs are considered progenitor cells with demonstrated ability to re-
pair bone defects and also have a potential variable for the development
of mesenchymal tissues. However the concentration of MSC in bone
Table 4
Mechanism of action and eﬃcacy of scaﬀold, growth factors and cell therapies in bone healing stimulation of diaphyseal fractures (Calcei and Rodeo, 2019; Schottel
and Warner, 2017; Malhotra et al., 2015; Boyce et al., 1999; Calori et al., 2015; Calori et al., 2008; Sen and Miclau, 2007).
Osteogenicity Osteoconductivity Osteoinductivity Growth factors
Autograft ++ +++ ++ ++
Allograft +++ +
Demineralized bone matrix (DBM) ++ +
Calcium phosphate
Hydroxyapatite
+
Bioactive glass ++
BMPs +++ +++
Platelet rich plasma (PRP) + ++ ++
Bone marrow aspirate concentrate (BMAC) +++ ++ ++
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marrow is< 1 on 100,000 cells or< 600 progenitor cells/cm3
(Hernigou et al., 2006), therefore, the ultimate goal of BMAC is to
concentrate the number of progenitor cells delivered in the aspirate.
Hernigou et al. reported that bone marrow from Iliac crest aspiration,
after concentration, contained> 2500 progenitor cells/cm3 (Hernigou
et al., 2006). Although the indications for the use of BMAC in the
treatment of acute fractures are not as well established, some authors
described the primary fracture ﬁxation with BMAC-enriched allografts
for complex shaft fractures and bone defect, as alternative to autografts
(Schottel and Warner, 2017; Jäger et al., 2011). The role of BMAC in
delayed unions and non-unions of long bones is well-known. BMAC can
be applied both alone or in combination with enriched scaﬀolds (au-
tografts, allografts and DBM), PRPs and BMPs. Clinical case series have
reported that bone marrow aspirate injection has a success of 75% to
90% in treating atrophic tibial and humeral non-unions (Rupp et al.,
2018; Hernigou et al., 2006; Desai et al., 2015; Goel et al., 2005;
Garnavos et al., 2010). Hernigou et al. proposed the use of BMAC alone
for tibial non-union reporting brilliant results. BMAC was injected
8months after the trauma in 60 patients, and union was obtained in
88% of cases at 4.5 months (Hernigou et al., 2006). Unfortunately, no
comparative studies of bone marrow aspirate injection with other non-
union treatment techniques, such as intramedullary nail dynamization,
exchange nailing, or compressive plating with autologous bone grafting
has been performed.
Platelet rich plasma (PRP) is an autologous blood concentrate sus-
pension of platelets obtained via centrifugation techniques. The bio-
logic rationale for its use in bone healing involves the local delivery of
cytokines that are released from a pool of degranulating platelets. Local
injection of PRP aim to mimic and augment the biological function of
the hematoma at the fracture site. Speciﬁcally, the granules in platelets
contain and release PDGF, transforming growth factor beta 1 (TGF-b1),
VEGF, epidermal growth factor, ﬁbroblast growth factor, and insulin-
like growth factor which have been addressed to enhance the healing
process of injured tissues (Oh et al., 2015). Although a number of
preclinical studies reported favourable results to the use of PRP for
fresh fracture enhancement (Wang and Rodeo, 2017), its clinical use in
long bone fractures is mainly limited to the treatment of delayed union
and non-union. In a prospective study, PRP for the treatment of 94 shaft
fracture non-unions (35 tibia, 30 femur, 11 humerus, 4 radius, 12 ulna,
2 with both radius and ulna) resulted in 87% rate of union at 4months
(Malhotra et al., 2015). In randomized controlled trial, PRP injections
were compared with exchange nailing for the treatment of 29 diaphy-
seal oligotrophic non-unions of tibia and femur, showing superior
healing rate in the PRP group compared with exchange nailing group
(93% vs 80%) (Duramaz et al., 2018). Despite early promising results,
at the moment, the grades of recommendation for PRP use in bone
healing indicates conﬂicting or poor-quality evidence and therefore
further investigation is needed (Wang and Rodeo, 2017).
6. Biophysical stimulation of fracture healing
Adjuvant biophysical therapies have been employed in trauma
surgery to optimize fracture-healing since 1950's, and their use had
particular diﬀusion in the area of delayed unions and nonunions
(Hannemann et al., 2014; Clin. Orthop. Relat. Res., 1977; Heckman
et al., 1994; Scott and King, 1994; Capone et al., 2011).
6.1. Pulsed electromagnetic ﬁelds
The primary clinical application of pulsed electromagnetic ﬁelds
(PEMF) was, in fact, nonunited fractures of long bones, with bone union
reported up to 80% (Scott and King, 1994). In 2011 a Cochrane me-
tanalysis showed inconclusive and insuﬃcient results to inform current
practice (Heckman et al., 1994). Other studies demonstrated successful
results in the early treatment of delayed union, but the eﬀects of the
PEMF on fresh fractures were unclear (Heckman et al., 1994; Scott and
King, 1994). In 2011, Adie et al. conducted a multicentre, double-blind,
randomized trial including 259 patients with acute tibial shaft frac-
tures. They concluded that adjuvant PEMF did not prevent secondary
surgical interventions for delayed union or nonunion and did not im-
prove radiographic union or patient-reported functional outcomes
(Adie et al., 2011).
In 2014, a metanalysis of RCTs by Hannemann et al. investigated
the eﬀects of PEMF bone growth stimulation in acute fractures. They
found signiﬁcant results that suggest that the use of PEMF in acute
diaphyseal fractures may accelerate the time to radiological and clinical
union (Hannemann et al., 2014). The main advantages were found in
patients who received conservative treatment rather than operative.
6.2. Low-intensity pulsed ultrasonography
Low-intensity pulsed ultrasonography (LIPUS) has also been applied
in clinical settings for the treatment of long-bone fractures of the upper
and lower extremities. First reports, provide good quality evidence on
this topic but with discordant results. Heckman et al. in a prospective,
randomized, double-blind trial with 77 closed tibia shaft fractures,
nonoperatively treated, reported lower time of radiological and clinical
union in the active-treatment group (96 ± 4.9 days) compared with
the control group (154 ± 13.7 days) (p= 0.0001) (Heckman et al.,
1994). On the contrary, Emami et al. in a prospective, randomized,
double-blind trial with 32 closed tibia shaft fractures, treated with
locked IMN, concluded that LIPUS treatment did not shorten healing
time in fresh tibial fractures treated with a reamed locked IMN (Emami
et al., 1999). In a Cochrane metanalysis of 12 trials, Griﬃn et al. as-
sessed the eﬀects of low-intensity ultrasound (LIPUS), high-intensity
focused ultrasound (HIFUS) and extracorporeal shockwave therapies
(ECSW) as part of the treatment of acute fractures in adults (Griﬃn
et al., 2012; Griﬃn et al., 2014). The authors stated that a potential
beneﬁt of ultrasound for the treatment of acute fractures of the lower
limb in adults cannot be excluded. However, the currently available
evidence is insuﬃcient to support the routine use of this intervention in
clinical practice, due to the clinical heterogeneity of the trial included.
7. Systemic pharmacological therapy
The process of consolidation and bone remodelling of a fracture is
strictly dependent by bone turnover and the calcium and phosphate
metabolism. Therefore, pharmacological interventions which could
modulate positively the healing process, have been recently merged to
the treatment algorithm, which evolved from a diamond to a pentagon
concept where the systemic therapy has the potential to represent the
ﬁfth interaction factor (Capone et al., 2014). Current research is being
carried out into oﬀ-label use of two classes of anti-osteoporotic drugs,
antiresorptive and anabolic agents, for complex conditions requiring
enhancement of bone repair such as complicated fractures and non-
union (Cheng and Shoback, 2019) (Table 5).
7.1. Bisphosphonates
Controversies exist on the usefulness of bisphosphonates (BP) on
fracture healing. As antiresorptive drugs, inhibit bone reabsorption by
blocking the action of osteoclasts, and this may cause a delay in bone
remodelling. Animal studies showed larger callus and stronger me-
chanical strength of femoral shaft fractures after bisphosphonates ad-
ministration in ovariectomized rats (Fu et al., 2013). Several studies
have evaluated the eﬀect of bisphosphonate therapy on osteoporotic
women with distal radius fractures, showing that post-fracture bi-
sphosphonate treatment led to increased bone density at the fracture
site compared to placebo (Colón-Emeric et al., 2011). Moreover, the use
of bisphosphonate in osteoporotic showed improved ﬁxation stability at
the bone – implant interface (Moroni et al., 2007). However weak
evidence exists on the eﬀects of bisphosphonates either to accelerate
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fracture healing or rescue impaired healing, and at the moment no
clinical study reported results of its human use in long bones diaphyseal
fractures (Hegde et al., 2016).
7.2. Denosumab
Denosumab (DMAB) is an anti-resorptive agent and monoclonal
antibody directed against the receptor for nuclear factor-kappa B ligand
(RANKL) and has a strong antiresorptive activity. The biggest evidence
on the eﬀect of DMAB for fracture healing originated from a subgroup
analysis of the FREEDOM study, a double-blind, placebo controlled trial
in post-menopausal women investigating fracture risk reduction by
denosumab vs placebo (Adami et al., 2012). Results around DMAB and
bone healing enhancement in non-vertebral fractures were substantially
neutral: DMAB did not seem to delay fracture-healing or contribute to
other complications, even when it is administered at or near the time of
the fracture. Even for DMAB, clinical studies reporting results of its
human use diaphyseal fractures are lacking.
7.3. Strontium ranelate
Strontium ranelate is an anti-osteoporotic drug and anabolic agent
which has a dual mode activity on bone promoting both bone formation
and its resorption, increasing the action of osteoblasts and reducing that
of osteoclasts (Marie et al., 2001). In experimental study in ovar-
iectomized rats with tibiae fracture, administration of strontium rane-
late promoted fracture healing, increasing callus, bone mineral density
and biomechanical strength at early period of fracture healing (4 weeks
post fracture). Regarding the use of strontium ranelate on fracture re-
pair in humans there are only reported clinical cases that indicate a
potential beneﬁt on long bones fractures (Alegre et al., 2012; Negri and
Spivacow, 2012).
7.4. Parathormone analogues
Currently two parathormone (PTH) analogues, PTH 1–34 (or ter-
iparatide) and PTH 1–84, are available for clinical treatment of osteo-
porosis (Díez-Pérez et al., 2019; Marongiu et al., 2018). The application
of these osteoanabolic agents for bone healing purposes in shaft frac-
tures of animal models have shown ﬁndings that indicates increased
callus volume, mineralization, and mechanical strength (Nakajima
et al., 2002; Nakazawa et al., 2005). However a wide range of diﬀerent
dosages and duration of the treatment have been proposed for both
animal and human models (Ota et al., 2019). Although early successful
clinical results were reported in two RCTs which analysed the eﬀect of
PTH (1–34) vs placebo in the treatment of distal radius and pelvis
fractures (Aspenberg et al., 2010; Peichl et al., 2011), evidence that
PTH analogues clinically improve fracture healing of long bones is
limited to case reports or small case series.
The main reported application of teriparatide (TPTD) in bone
healing is the enhancement of impaired diaphyseal fractures, such as
femoral, tibial and humeral non-unions with mostly stated favourable
reports (Nozaka et al., 2014; Takeuchi et al., 2019; Giannotti et al.,
2013). In a prospective non-randomized non-controlled study, 32 pa-
tients with non-unions of femur, tibia, humerus and metatarsal bones
were treated with 20 μg per day of teriparatide. After average
4.1 ± 1.5months after PTH treatment, 30 of the 32 patients (95% of
the cases) obtained a stable osseous consolidation of the non-union and
regained full and pain-free weight-bearing (Kastirr et al., 2019).
Recently interest has focused on the use of teriparatide for the
treatment of atypical femoral fractures (AFFs). AFFs are sub-trochan-
teric and diaphyseal fractures of the femur (between the lesser tro-
chanter and proximal to the supracondylar ﬂare) that occur after
minimal or absence of trauma and are associated with long-term bi-
sphosphonate or denosumab use (Lepri et al., 2018b; Shane et al.,
2014). Several studies strongly support the use of PTH 1–34 in pro-
moting bone union in AFFs (Miyakoshi et al., 2015; Watts et al., 2017;
Chiang et al., 2013). Miyakoshi et al. (Miyakoshi et al., 2015) retro-
spectively reviewed 45 consecutive AFFs in 34 Japanese patients who
received long-term oral BPs. For all AFFs treated surgically, mean time
to fracture healing was signiﬁcantly better in the TPTD group
(5.4 ± 1.5months) than in the non-TPTD group (8.6 ± 4.7months,
p= 0.012), and the frequency of delayed healing or non-union was
signiﬁcantly lower in the TPTD group than in the non-TPTD group
(p= 0.014). Both Watts et al. (Watts et al., 2017) and Chiang et al.
(Chiang et al., 2013) prospectively evaluated patients with AFFs and a
history of previous BPs therapy. In their series, administration of 20 μg
of daily TPTD for 6 to 24months was associated with an increase in
bone turnover markers, but, on the other hand, there was no consistent
eﬀect on fracture healing.
Teriparatide has been proposed for its possible beneﬁts in the
treatment of another type of shaft fractures: periprosthetic femoral
fractures (PFFs). Even if encouraging results of case series are reported
(Papaiordanidou et al., 2014; Kim et al., 2016), unfortunately there's a
lack of high level clinical studies.
8. Conclusions
The main complication after the treatment of diaphyseal fractures is
still represented by delayed union and nonunion. In order to avoid
these threatening events, surgical and non-surgical approach has to be
tailored diﬀerently for each fracture and each patient according to
Table 5
Summary of clinical evidence of pharmacological agents' eﬀect on bone repair of long bones shaft fractures (Capone et al., 2014; Brandi, 2012).a
Agent Class Clinical evidence Quality of evidence
Calcium/vitamin D Supplemental May increase bone mineral density at fracture site Weak
Bisphosphonates Antiresorptive No deﬁnitive evidence to suggest inhibition of healing.
Unclear if there are beneﬁts in augmenting healing.
May increase BMD at fracture site when given 2 weeks after fracture.
Improve ﬁxation at bone implant interface
Weak
Denosumab Antiresorptive Does not delay healing
Unclear if beneﬁts in enhancing healing
Weak
Strontium ranelate Anabolic Case reports suggest beneﬁt on fracture healing.
Increased callus resistance and volume.
May facilitate fusion after delayed union or nonunion.
Weak
Teriparatide Anabolic Accelerated healing of long bone fractures and improved implant stabilization.
Some evidence for improved healing of delayed unions, non-unions, atypical femoral fractures and periprosthetic
femoral fractures
Moderate
a Quality of clinical evidence was classiﬁed as weak, moderate, or strong based on the level of evidence of existing literature. A “weak” rating consisted of mainly
level 3–4 studies. “Moderate” indicated multiple level 2 studies or conﬂicting level 1 data. “Strong” evidence consisted of multiple level 1 studies with generally
consistent ﬁndings.
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biological and biomechanical basis of bone healing.
In the last decade, the “diamond concept” for fracture healing, has
given equal importance to the mechanical stability and the biologic
environment, and oﬀered a new paradigm for complex fractures and
impaired union management. In this poly-therapeutic approach,
modern bio-engineering technologies play a crucial role improving the
traditional ﬁxation techniques with other surgical and non-surgical
approaches (Calcei and Rodeo, 2019). Additional local biological en-
hancement by addition of a scaﬀold, growth factors, and cell therapies
whilst preserving the local vascular supply. The evidence available
nowadays showed convincing results supporting the use of ‘poly-
therapy’ with the diamond concept over ‘monotherapy’, although some
of the studies exploited all the aspects of the diamond concept only for
high-risk patients, which may have biased the results (Andrzejowski
and Giannoudis, 2019). Systemic drug therapies for long bones bone
healing enhancement remains limited to anti-osteoporotic anti-re-
sorptive and anabolic agents. The use of teriparatide in selected shaft
fractures types, such as atypical femoral fractures, periprosthetic fe-
moral fractures and recalcitrant non-unions, have yielded positive re-
sults but limited to case reports and case series. Several ongoing clinical
trials, examining the eﬀects of local enhancement approaches and the
use of systemic anabolic agents would eventually provide the needed
evidence on this topic. In the future results derived from computational
simulation, ﬁnite element analysis and new imaging technologies such
as those based on 3D modelling software, could add information and
allow to monitor the bone healing process (Marongiu et al., 2020a; Lal
and Patralekh, 2018; Wang et al., 2017; Marongiu et al., 2020b), in
order to choose the best timing for each of the proposed treatment.
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